Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer
Terence W. Friedlander(University of California, San Francisco), Pamela L. Paris(University of California, San Francisco)
Cited by 127
Related Papers
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
|JAMA Oncology|2017|846
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
|BMC Cancer|2016|105
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer
|The Journal of Urology|2015|88
Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer
|Journal of Nuclear Medicine|2024|26
PD09-12 THE USE OF <sup>68</sup> Ga-FAP-2286 PET IMAGING IN PATIENTS WITH LOCALIZED BLADDER CANCER
|The Journal of Urology|2023|2